| Literature DB >> 30388820 |
Thi Thanh Van Trinh1, Bich Ngan Truong2, Arlette Longeon3, Thi Mai Huong Doan4, Alexandre Deville5, Van Minh Chau6, Van Cuong Pham7, Marie-Lise Bourguet-Kondracki8.
Abstract
Chemical investigation of the methanol extract of the Vietnamese marine sponge Ircinia echinata led to the isolation of six new 9α-hydroxy-5α,6α-epoxysterols: 5α,6α-epoxycholesta-7,22(E)-dien-3β,9α-diol (1), 5α,6α-epoxycholesta-7,24(28)-dien-3β,9α-diol (2), (24R)-5α,6α-epoxy-24-ethyl-cholesta-7-en-3β,9α-diol (3), 5α,6α-epoxycholesta-7-en-3β,9α-diol (4), (24S)-5α,6α-epoxyergosta-7,22-dien-3β,9α-diol (5), and (24R)-5α,6α-epoxy-24-methyl-cholesta-7-en-3β,9α-diol (6) along with the known 5α-6α-epoxysterols: 5α,6α-epoxystigmasta-7-en-3β-ol (7), 5α,6α-epoxystigmasta-7,22-dien-3β-ol (8), and 5α,6α-epoxyergosta-7-en-3β-ol (9). Their structures and their configurations were established on the basis of high resolution mass spectra and extensive 1D and 2D NMR spectroscopic data and by comparison with the literature. Their cytotoxic activity, evaluated against three human cancer cell lines, MCF-7, Hep-G2 and LU-1, revealed that only compounds 3 and 4 exhibited significant antiproliferative activity and compound 3 showed a selective inhibition towards the MCF-7 human breast cancer cells.Entities:
Keywords: 9α-hydroxy-5α,6α-epoxysterols; Ircinia echinata; cytotoxicity; marine sponge
Mesh:
Substances:
Year: 2018 PMID: 30388820 PMCID: PMC6267468 DOI: 10.3390/md16110424
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structure of 5α,6α-epoxysterols 1–9 isolated from Ircinia echinata.
1H NMR data of compounds 1–6 recorded in CD3OD (δH, multiplicity, J in Hz).
| No | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| 1 | 2.20 dt (4.3, 13.5) | 2.20 dt (4.3, 13.5) | 2.20 dt (4.3, 13.8) | 2.20 dt (4.2, 13.8) | 2.20 dt (4.2, 13.8) | 2.20 dt (4.2, 13.8) |
| 1.35 m | 1.35 m | 1.36 m | 1.35 m | 1.36 m | 1.36 m | |
| 2 | 1.86 m | 1.86 m | 1.88 m | 1.85 m | 1.86 m | 1.86 m |
| 1.51 m | 1.50 m | 1.52 m | 1.52 m | 1.51 m | 1.51 m | |
| 3 | 4.00 m | 4.00 m | 4.00 m | 4.00 m | 4.0 m | 4.0 m |
| 4 | 1.66 m | 1.66 m | 1.66 m | 1.67 m | 1.66 m | 1.67 m |
| 2.11 dd (11.4, 13.8) | 2.12 dd (11.2, 13.5) | 2.12 dd (11.2, 13.8) | 2.12 dd (11.4, 13.2) | 2.12 dd (11.4, 13.2) | 2.12 dd (11.4, 13.8) | |
| 6 | 3.65 m | 3.64 m | 3.66 m | 3.66 m | 3.65 m | 3.65 m |
| 7 | 5.33 m | 5.33 m | 5.34 dd (1.8, 4.8) | 5.34 dd (2.4, 4.8) | 5.34 dd (2.4, 4.8) | 5.33 dd (1.8, 4.8) |
| 11 | 1.60 m | 1.97 m | 1.97 m | 1.97 m | 1.60 m | 1.60 m |
| 1.91 m | 1.59 m | 1.60 m | 1.60 m | 1.90 m | 1.97 m | |
| 12 | 1.61 m | 1.60 m | 1.59 m | 1.59 m | 1.61 m | 1.60 m |
| 1.83 m | 1.86 m | 1.86 m | 1.86 m | 1.83 m | 1.86 m | |
| 14 | 2.49 m | 2.50 m | 2.49 m | 2.50 m | 2.50 m | 2.49 m |
| 15 | 1.55 m | 1.61 m | 1.61 m | 1.61 m | 1.56 m | 1.61 m |
| 1.48 m | 1.51 m | 1.53 m | 1.53 m | 1.48 m | 1.52 m | |
| 16 | 1.34 m | 1.36 m | 1.35 m | 1.34 m | 1.34 m | 1.34 m |
| 1.80 m | 1.90 m | 1.91 m | 1.90 m | 1.80 m | 1.91 m | |
| 17 | 1.37 m | 1.36 m | 1.36 m | 1.34 m | 1.37 m | 1.34 m |
| 18 | 0.66 s | 0.65 s | 0.65 s | 0.65 s | 0.66 s | 0.65 s |
| 19 | 1.12 s | 1.12 s | 1.12 s | 1.12 s | 1.12 s | 1.12 s |
| 20 | 2.05 m | 1.45 m | 1.41 m | 1.41 m | 2.04 m | 1.41 m |
| 21 | 1.03 d (6.5) | 0.99 d (6.8) | 0.97 d (6.5) | 0.96 d (6.6) | 1.03 d (6.6) | 0.96 d (6.6) |
| 22 | 5.24 dd (8.0, 15.0) | 1.18 m, 1.60 m | 1.60 m, 1.07 m | 1.41 m, 1.14 m | 5.20 m | 1.11 m, 1.40 m |
| 23 | 5.32 m | 1.92 m, 2.13 m | 1.25 m | 1.40 m, 1.19 m | 5.21 m | 1.28 m, 1.53 m |
| 24 | 1.84 m | 0.96 m | 1.16 m | 1.85 m | 1.23 m | |
| 25 | 1.58 m | 2.24 m | 1.71 m | 1.53 m | 1.47 m | 1.55 m |
| 26 | 0.89 d (6.7) | 1.03 d (6.7) | 0.86 d (6.8) | 0.89 d (6.6) | 0.88 d (7.2) | 0.88 d (7.2) |
| 27 | 0.89 d (6.7) | 1.04 d (6.7) | 0.84 d (6.8) | 0.89 d (6.6) | 0.86 d (7.2) | 0.83 d (7.2) |
| 28 | 4.67 brs, 4.73 brs | 1.35 m, 1.18 m | 0.94 d (7.2) | 0.81 d (7.2) | ||
| 29 | 0.88 m |
13C NMR data for compounds 1–6 recorded in CD3OD.
| No | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| 1 | 28.2 t | 28.2 t | 28.3 t | 28.2 t | 28.3 t | 28.3 t |
| 2 | 31.6 t | 31.6 t | 31.6 t | 31.6 t | 31.6 t | 31.6 t |
| 3 | 68.2 d | 68.2 d | 68.2 d | 68.2 d | 68.2 d | 68.2 d |
| 4 | 40.7 t | 40.7 t | 40.8 t | 40.7 t | 40.7 t | 40.7 t |
| 5 | 78.9 s | 78.9 s | 78.9 s | 78.9 s | 78.9 s | 78.9 s |
| 6 | 73.7 d | 73.7 d | 73.7 d | 73.7 d | 73.7 d | 73.7 d |
| 7 | 121.0 d | 121.1 d | 121.0 d | 121.0 d | 121.0 d | 121.0 d |
| 8 | 143.8 s | 143.8 s | 143.8 s | 143.8 s | 143.8 s | 143.8 s |
| 9 | 76.1 s | 76.0 s | 76.1 s | 76.0 s | 76.1 s | 76.1 s |
| 10 | 41.4 s | 41.4 s | 41.4 s | 41.4 s | 41.4 s | 41.4 s |
| 11 | 29.1 t | 28.9 t | 29.0 t | 28.9 t | 29.2 t | 29.0 t |
| 12 | 36.5 t | 36.6 t | 36.6 t | 36.6 t | 36.5 t | 36.5 t |
| 13 | 44.8 s | 44.9 s | 44.9 s | 44.9 s | 44.8 s | 44.8 s |
| 14 | 51.9 d | 51.8 d | 51.8 d | 51.8 d | 51.9 d | 51.8 d |
| 15 | 24.0 t | 24.1 t | 24.1 t | 24.1 t | 24.0 t | 24.0 t |
| 16 | 29.3 t | 29.1 t | 29.2 t | 29.1 t | 29.6 t | 29.1 t |
| 17 | 57.3 d | 57.4 d | 57.4 d | 57.5 d | 57.4 d | 57.5 d |
| 18 | 12.2 q | 12.0 q | 12.2 q | 12.0 q | 12.2 q | 12.0 q |
| 19 | 22.2 q | 22.2 q | 22.2 q | 22.2 q | 22.2 q | 22.2 q |
| 20 | 41.8 d | 37.3 d | 37.9 d | 37.5 d | 41.9 d | 37.5 d |
| 21 | 21.5 q | 19.3 q | 19.4 q | 19.3 q | 21.5 q | 19.3 q |
| 22 | 139.1 d | 35.8 t | 35.0 t | 37.2 t | 137.2 d | 35.0 t |
| 23 | 127.8 d | 32.1 t | 27.2 t | 24.9 t | 133.4 d | 31.4 t |
| 24 | 43.1 t | 157.3 s | 47.4 d | 40.6 t | 44.6 d | 40.3 d |
| 25 | 29.8 d | 34.9 d | 30.2 d | 29.2 d | 34.5 d | 33.7 d |
| 26 | 22.7 q | 22.3 q | 20.1 q | 22.9 q | 20.7 q | 20.5 q |
| 27 | 22.7 q | 22.4 q | 19.4 q | 23.2 q | 20.1 q | 18.5 q |
| 28 | 106.1 t | 24.1 t | 18.6 q | 15.8 q | ||
| 29 | 12.7 q |
Figure 2Selected HMBC and COSY correlations in compound 1.
Figure 3Key NOESY correlations of compound 1.
Figure 4Selected HMBC correlations in compound 4.
Cytotoxic evaluation of the active 5α,6α-epoxysterols 3–4 against human cancer cell lines (IC50 values are expressed in µg.mL−1).
| Compound | Human Cancer Cell Lines | ||
|---|---|---|---|
| MCF-7 | HepG-2 | Lu-1 | |
| 15.88 ± 1.36 | >32 | >32 | |
| 15.88 ± 0.09 | 15.95 ± 0.20 | 22.92 ± 0.09 | |
| Ellipticine | 0.34 ± 0.01 | 0.38 ± 0.05 | 0.41 ± 0.04 |
Ellipticine was used as positive control. Values presented as the mean ± (SEM) (n = 3).